- Home
- SHO vs CLDX Comparison
SHO vs CLDX Comparison
Compare SHO & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHO
- CLDX
- Stock Information
- Founded
- SHO 1995
- CLDX N/A
- Country
- SHO United States
- CLDX United States
- Employees
- SHO N/A
- CLDX N/A
- Industry
- SHO Hotels/Resorts
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SHO Consumer Discretionary
- CLDX Health Care
- Exchange
- SHO Nasdaq
- CLDX Nasdaq
- Market Cap
- SHO 1.8B
- CLDX 1.9B
- IPO Year
- SHO 1995
- CLDX 2008
- Fundamental
- Price
- SHO $9.41
- CLDX $26.31
- Analyst Decision
- SHO Hold
- CLDX Buy
- Analyst Count
- SHO 7
- CLDX 10
- Target Price
- SHO $9.21
- CLDX $43.80
- AVG Volume (30 Days)
- SHO 1.7M
- CLDX 914.2K
- Earning Date
- SHO 11-07-2025
- CLDX 11-10-2025
- Dividend Yield
- SHO 3.93%
- CLDX N/A
- EPS Growth
- SHO N/A
- CLDX N/A
- EPS
- SHO 0.01
- CLDX N/A
- Revenue
- SHO $937,930,000.00
- CLDX $2,599,000.00
- Revenue This Year
- SHO $5.78
- CLDX N/A
- Revenue Next Year
- SHO $5.62
- CLDX N/A
- P/E Ratio
- SHO $947.00
- CLDX N/A
- Revenue Growth
- SHO 3.04
- CLDX N/A
- 52 Week Low
- SHO $7.45
- CLDX $14.40
- 52 Week High
- SHO $12.41
- CLDX $29.05
- Technical
- Relative Strength Index (RSI)
- SHO 54.00
- CLDX 56.44
- Support Level
- SHO $8.95
- CLDX $24.53
- Resistance Level
- SHO $9.39
- CLDX $26.63
- Average True Range (ATR)
- SHO 0.29
- CLDX 1.34
- MACD
- SHO -0.01
- CLDX 0.25
- Stochastic Oscillator
- SHO 45.31
- CLDX 94.04
About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.
Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in Califiornia which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its hotel ownership segment.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.